Preclinical antitumor activity of
            S
            ‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

Hidekazu Tanaka; Michinari Hirata; Satomi Shinonome; Toru Wada; Motofumi Iguchi; Keiji Dohi; Makiko Inoue; Yukichi Ishioka; Kanji Hojo; Tomomi Yamada; Tatsuya Sugimoto; Koichi Masuno; Ken‐ichi Nezasa; Norihito Sato; Kenji Matsuo; Shuji Yonezawa; Eugene P. Frenkel; Michitaka Shichijo

doi:10.1111/cas.12449

Preclinical antitumor activity of S ‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2

Cancer Science ◽

10.1111/cas.12449 ◽

2014 ◽

Vol 105 (8) ◽

pp. 1040-1048 ◽

Cited By ~ 7

Author(s):

Hidekazu Tanaka ◽

Michinari Hirata ◽

Satomi Shinonome ◽

Toru Wada ◽

Motofumi Iguchi ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Antitumor Activity ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03731-2 ◽

2021 ◽

Author(s):

Yu-Jin Wang ◽

Qing-Wen Wang ◽

Dong-Hu Yu ◽

Cong-Kuan Song ◽

Zi-Xin Guo ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"1

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01464.x ◽

2003 ◽

Vol 94 (5) ◽

pp. 453-458 ◽

Cited By ~ 36

Author(s):

Seiji Yano ◽

Takanori Kanematsu ◽

Toyokazu Miki ◽

Yoshinori Aono ◽

Masahiko Azuma ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bronchioloalveolar Carcinoma ◽

Epidermal Growth

Download Full-text

Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor

Cancer Science ◽

10.1111/j.1349-7006.2007.00613.x ◽

2007 ◽

Vol 98 (12) ◽

pp. 1977-1984 ◽

Cited By ~ 22

Author(s):

Tsuyoshi Suzuki ◽

Akihiro Fujii ◽

Junichi Ohya ◽

Yusaku Amano ◽

Yasunori Kitano ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Pharmacological Characterization ◽

Epidermal Growth

Download Full-text

First Reported Case of Unexpected Response to an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the I744M Uncommon EGFR Mutation

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.06.002 ◽

2015 ◽

Vol 16 (6) ◽

pp. e259-e261 ◽

Cited By ~ 4

Author(s):

Emmanuelle Kempf ◽

Ludovic Lacroix ◽

Jean-Charles Soria

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor

Cancer Science ◽

10.1111/j.1349-7006.2008.00847.x ◽

2008 ◽

Vol 99 (8) ◽

pp. 1611-1617 ◽

Cited By ~ 44

Author(s):

Kazuko Matsumoto ◽

Hideyuki Yokote ◽

Tokuzo Arao ◽

Mari Maegawa ◽

Kaoru Tanaka ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Activity ◽

Epidermal Growth

Download Full-text

Paronychia Induced by Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

The Journal of Dermatology ◽

10.1111/j.1346-8138.2003.tb00387.x ◽

2003 ◽

Vol 30 (3) ◽

pp. 261-262 ◽

Cited By ~ 27

Author(s):

Junji Nakano ◽

Mitsutaka Nakamura

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib

Annals of Oncology ◽

10.1093/annonc/mdg352 ◽

2003 ◽

Vol 14 (8) ◽

pp. 1330-1331 ◽

Cited By ~ 20

Author(s):

R. Govindan ◽

D. Behnken ◽

W. Read ◽

H. McLeod

Keyword(s):

Wound Healing ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Phase I and pharmacokinetic (PK) Study of CP-724,714, an oral human epidermal growth factor receptor-2 (HER-2) selective tyrosine kinase inhibitor

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3082 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3082-3082

Author(s):

P. N. Munster ◽

M. Mita ◽

C. Britten ◽

S. Minton ◽

S. Moulder ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Her 2 ◽

Epidermal Growth

Download Full-text